Literature DB >> 31473885

Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.

Kosuke Murakami1, Yasushi Kotani1, Reona Shiro1, Hisamitsu Takaya1, Hidekatsu Nakai1, Noriomi Matsumura2.   

Abstract

BACKGROUND: Endometriosis is a risk factor for ovarian cancer. Endometriosis-associated ovarian cancer (EAOC), most commonly clear cell carcinoma, is believed to develop from ovarian endometrial cysts. In this study, we reviewed published cases of EAOC considered to have developed from endometrial cysts, and focused on the observation period.
METHODS: We searched for articles published since January 2000 that reported cases of ovarian cancer thought to have originated from endometrial cysts using PubMed, Web of Science, and Ichushi-Web. The period from the start of follow-up of the endometrial cyst to the diagnosis of ovarian cancer was calculated.
RESULTS: Seventy-nine cases were identified from 32 articles. The median period from the diagnosis of endometrial cysts to the diagnosis of ovarian cancer was only 36 months. Approximately 75% of cases developed into cancer within 60 months and most cases developed within 120 months.
CONCLUSION: Our results suggest that clinically detectable cysts subsequently diagnosed as ovarian cancer might already have contained cancer cells. Therefore, the mechanism of EAOC development needs to be re-examined and appropriate management guidelines need to be developed.

Entities:  

Keywords:  Clear cell carcinoma; Endometrial cyst; Endometrioid carcinoma; Endometriosis; Endometriosis-associated ovarian cancer

Mesh:

Year:  2019        PMID: 31473885     DOI: 10.1007/s10147-019-01536-5

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  25 in total

1.  Endometrioid adenocarcinoma of the ovary arising from endometriosis and presenting as an acute abdomen.

Authors:  D Maruthini; A Amin; J Buxton
Journal:  J Obstet Gynaecol       Date:  2007-07       Impact factor: 1.246

Review 2.  Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.

Authors:  Katsutoshi Oda; Junzo Hamanishi; Koji Matsuo; Kosei Hasegawa
Journal:  Gynecol Oncol       Date:  2018-09-12       Impact factor: 5.482

3.  Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan.

Authors:  H Kobayashi; K Sumimoto; N Moniwa; M Imai; K Takakura; T Kuromaki; E Morioka; K Arisawa; T Terao
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

Review 4.  Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?

Authors:  Paolo Vercellini; Paola Viganò; Laura Buggio; Sofia Makieva; Giovanna Scarfone; Fulvia Milena Cribiù; Fabio Parazzini; Edgardo Somigliana
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2018-02-15       Impact factor: 5.237

5.  Development of ovarian cancer after excision of endometrioma.

Authors:  Hirofumi Haraguchi; Kaori Koga; Masashi Takamura; Tomoko Makabe; Fusako Sue; Mariko Miyashita; Yoko Urata; Gentaro Izumi; Miyuki Harada; Tetsuya Hirata; Yasushi Hirota; Osamu Wada-Hiraike; Katsutoshi Oda; Kei Kawana; Tomoyuki Fujii; Yutaka Osuga
Journal:  Fertil Steril       Date:  2016-08-18       Impact factor: 7.329

Review 6.  Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.

Authors:  Hiroaki Itamochi; Junzo Kigawa; Naoki Terakawa
Journal:  Cancer Sci       Date:  2008-04       Impact factor: 6.716

Review 7.  Endometriosis-associated Ovarian Cancers.

Authors:  Michael S Anglesio; Paul J Yong
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

8.  Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.

Authors:  Naoko Nishio; Aki Kido; Masako Kataoka; Ryo Kuwahara; Kyoko Nakao; Yasuhisa Kurata; Noriomi Matsumura; Masaki Mandai; Kaori Togashi
Journal:  Eur J Radiol       Date:  2018-06-13       Impact factor: 3.528

9.  The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors:  Patrick O Brown; Chana Palmer
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

10.  Bilateral Ovarian Clear Cell Carcinoma Arising in 17 Year Longstanding History of Bilateral Ovarian Endometriosis.

Authors:  Thin Thin Win; Nik Mohamed Zaki Nik Mahmood; Saung Oo Ma; Mazita Ismail
Journal:  Iran J Pathol       Date:  2017-01-01
View more
  8 in total

1.  Screening differentially expressed genes between endometriosis and ovarian cancer to find new biomarkers for endometriosis.

Authors:  Zhenzhen Lu; Ying Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 2.  A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis.

Authors:  Xiaolin Qing; Liting Liu; Xiguang Mao
Journal:  Comput Math Methods Med       Date:  2022-05-25       Impact factor: 2.809

3.  Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

Authors:  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

4.  Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.

Authors:  Chen-Yu Huang; Wen-Hsun Chang; Hsin-Yi Huang; Chao-Yu Guo; Yiing-Jenq Chou; Nicole Huang; Wen-Ling Lee; Peng-Hui Wang
Journal:  Clin Epidemiol       Date:  2020-06-18       Impact factor: 4.790

5.  Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features.

Authors:  Kuan-Ju Huang; Ying-Xuan Li; Chin-Jui Wu; Wen-Chun Chang; Lin-Hung Wei; Bor-Ching Sheu
Journal:  J Ovarian Res       Date:  2022-07-14       Impact factor: 5.506

6.  Multivariate logistic regression analysis of the correlation between five biomarkers and ovarian cancer in patients with intermediate-risk: A prospective cross-sectional study.

Authors:  Zhen Liu; Jingjing Wu; Xiuli Wang; Xiaoyang Ji
Journal:  Front Cell Dev Biol       Date:  2022-08-31

7.  Predictive factors of surgical site infection after hysterectomy for endometrial carcinoma: a retrospective analysis.

Authors:  Lijuan Shi; Qiao Gu; Fenghua Zhang; Daoyun Li; Wenfeng Ye; Yan Zhong; Xiu Shi
Journal:  BMC Surg       Date:  2021-06-14       Impact factor: 2.102

8.  Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.

Authors:  Chen-Yu Huang; Min Cheng; Na-Rong Lee; Hsin-Yi Huang; Wen-Ling Lee; Wen-Hsun Chang; Peng-Hui Wang
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.